Effectiveness of Ultrasound Combine TENS in Treatment of Upper Trapezius Myofascial Pain
NCT ID: NCT01742546
Last Updated: 2013-02-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2012-06-30
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Percutaneous Electrolysis of the Upper Trapezius in Chronic Neck Pain
NCT07294651
Effect of Vagus Nerve Stimulation on Trapezius Trigger Point
NCT07045324
Acute Effects of TENS on Cervical Muscle Stiffness and Pain in Neck Pain
NCT07244861
The Antalgic Effect of Pulse Frequency and Pad Size of TENS on Blunt Pressure Pain
NCT01999595
Which Type of Transcutaneous Electrical Nerve Stimulation is More Effective in Myofascial Pain Syndrome?
NCT04645095
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Therapeutic ultrasound combine TENS
Use therapeutic ultrasound with simultaneous TENS for 10 minutes/session for 10 sessions/course.
The therapeutic ultrasound machine in this study was Sonopuls 492 TM (Enraf-Nonius), this device has treatment head described by the manufacturers as having surface area as 5.8 cm2, ERA (Effective Radiating Area) of 5.0 cm2 and BNR (Beam Non-uniform Ratio) as max. 5.0. For electrotherapy unit which composes of 2 channels, output characteristics are constant current (CC) or constant voltage (CV), resolution of output signal is in steps of 0.2 mA and timer is limited to 30 minutes during ultrasound and combination therapy are operated.
Therapeutic ultrasound combine TENS
Use ultrasound treatment parameters as continuous mode, 1 MHz in frequency and 1 w/cm2 for intensity and circular stroking of sound head over affected upper trapezius muscle throughout treatment period. For simultaneous TENS parameters as pulse frequency 100-150 pps, pulse duration 50- 80 µs and adjust amplitude as produce tingling for 10 minutes. The skin electrode should be placed near the active trigger in area of trapezius muscle. And the control group received sham TENS by turn-off electrical current.
The therapeutic ultrasound machine in this study was Sonopuls 492 TM (Enraf-Nonius).
Therapeutic ultrasound with sham TENS
Use the same therapeutic ultrasound machine and place the electrode as experimental group but turn-off electrical current during treatment period
Therapeutic ultrasound combine TENS
Use ultrasound treatment parameters as continuous mode, 1 MHz in frequency and 1 w/cm2 for intensity and circular stroking of sound head over affected upper trapezius muscle throughout treatment period. For simultaneous TENS parameters as pulse frequency 100-150 pps, pulse duration 50- 80 µs and adjust amplitude as produce tingling for 10 minutes. The skin electrode should be placed near the active trigger in area of trapezius muscle. And the control group received sham TENS by turn-off electrical current.
The therapeutic ultrasound machine in this study was Sonopuls 492 TM (Enraf-Nonius).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Therapeutic ultrasound combine TENS
Use ultrasound treatment parameters as continuous mode, 1 MHz in frequency and 1 w/cm2 for intensity and circular stroking of sound head over affected upper trapezius muscle throughout treatment period. For simultaneous TENS parameters as pulse frequency 100-150 pps, pulse duration 50- 80 µs and adjust amplitude as produce tingling for 10 minutes. The skin electrode should be placed near the active trigger in area of trapezius muscle. And the control group received sham TENS by turn-off electrical current.
The therapeutic ultrasound machine in this study was Sonopuls 492 TM (Enraf-Nonius).
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical diagnosis of myofascial trigger point pain at upper trapezius muscle(s) persisted more than 1 week but less than 6 months before recruitment time, first or recurrence episodes
* Baseline VAS more than or equal 4 at upper trapezius muscle
Exclusion Criteria
* Had experience of ultrasound combine transcutaneous electrical nerve stimulation (TENS)
* Had history of accidence or severe trauma to shoulder region
* Had serious musculoskeletal condition that need surgical intervention such as acute shoulder subluxation, abnormal neurological examination
* Insensate skin or sensory impairment around shoulder area
* Skin infection at shoulder area
* Had contraindication for U/S such as cardiac pacemaker, implantation, malignancy in relevant area, bleeding disorder, acute inflammatory musculoskeletal disease, pregnancy, lactation
* Unable to communication
* Unable to complete treatment session and follow protocol
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sirindhorn National Medical Rehabilitation Centre
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bootsakorn Loharjun, MD
Dr.Bootsakorn Loharjun, MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bootsakorn Loharjun, Medical Doctor
Role: PRINCIPAL_INVESTIGATOR
Sirindhorn National Medical Rehabilitation Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sirindhorn National Medical Rehabilitation Centre
Muang, Changwat Nonthaburi, Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SNMRC001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.